HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Liang, R. Articles by van Drunen Littel-van den Hurk, S. Search for Related Content PubMed PubMed Citation Articles by Liang, R. Articles by van Drunen Littel-van den Hurk, S. Agricola Articles by Liang, R. Articles by van Drunen Littel-van den Hurk, S.

Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle

Vaccine and Infectious Disease Organization, University of Saskatchewan, 120 Veterinary Road, SK S7N 5E3, Canada

Correspondence
Sylvia van Drunen Littel-van den Hurk
sylvia.vandenhurk{at}usask.ca

The objective of this study was to develop an optimal vaccination strategy for Bovine viral diarrhea virus (BVDV). The E2 protein of BVDV plays a major protective role against BVDV infection. In order to be able to compare DNA, protein and DNA prime–protein boost regimens, a plasmid was constructed encoding a secreted form of the NADL strain E2 protein (pMASIA-tPAsE2). Furthermore, a pure secreted recombinant E2 (rE2) protein was produced. The rE2 protein was formulated with a combination of Emulsigen and CpG oligodeoxynucleotide. Groups of calves were immunized with pMASIA-tPAsE2 or with rE2, or first with pMASIA-tPAsE2 and then with rE2. To evaluate the protection against BVDV, calves were challenged with BVDV strain NY-1 after the last immunization. Although all immunized calves developed humoral and cellular immune responses, the antibody responses in the DNA prime–protein boost group were stronger than those elicited by either the DNA vaccine or the protein vaccine. In particular, E2-specific antibody titres were enhanced significantly after boosting the E2 DNA-primed calves with rE2 protein. Moreover, protection against BVDV challenge was obtained in the calves treated with the DNA prime–protein boost vaccination regimen, as shown by a significant reduction in weight loss, viral excretion and lymphopenia, compared with the unvaccinated calves and the animals immunized with the DNA or protein only. These results demonstrate the advantage of a DNA prime–protein boost vaccination approach in an outbred species.

This article has been cited by other articles:

				R. Liang, J. V. van den Hurk, A. Landi, Z. Lawman, D. Deregt, H. Townsend, L. A. Babiuk, and S. van Drunen Littel-van den Hurk DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge J. Gen. Virol., February 1, 2008; 89(2): 453 - 466. [Abstract] [Full Text] [PDF]

				E. N. T. Meeusen, J. Walker, A. Peters, P.-P. Pastoret, and G. Jungersen Current Status of Veterinary Vaccines Clin. Microbiol. Rev., July 1, 2007; 20(3): 489 - 510. [Abstract] [Full Text] [PDF]